← Back to Search

Neuromodulation

Transcutaneous Spinal Cord Neuromodulation to Normalize Autonomic Phenotypes

N/A
Waitlist Available
Led By Ryan Solinsky, MD
Research Sponsored by Spaulding Rehabilitation Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, average 3 months
Awards & highlights
No Placebo-Only Group

Summary

This trial is looking at whether or not transcutaneous spinal cord stimulation can help improve autonomic nervous system function in people with spinal cord injury.

Eligible Conditions
  • Dysautonomia
  • Autonomic Dysreflexia
  • Spinal Cord Injury
  • Neurogenic Orthostatic Hypotension

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, average 3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, average 3 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Valsalva Maneuver Phase II
Secondary study objectives
Beat-to-beat blood pressure
Beat-to-beat heart rate
Continuous galvanic skin response
+3 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Individuals without spinal cord injuryExperimental Treatment3 Interventions
Group II: Individuals with spinal cord injuryExperimental Treatment4 Interventions
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Tests of sympathetic inhibition
2022
N/A
~10
Tests of sympathetic activation
2022
N/A
~10
Testing of autonomic dysreflexia
2022
N/A
~10
Transcutaneous spinal cord stimulation
2019
N/A
~40

Find a Location

Who is running the clinical trial?

Spaulding Rehabilitation HospitalLead Sponsor
139 Previous Clinical Trials
11,097 Total Patients Enrolled
Medical University of South CarolinaOTHER
976 Previous Clinical Trials
7,398,983 Total Patients Enrolled
Ryan Solinsky, MDPrincipal InvestigatorSpaulding Rehabilitation Hospital / Harvard Medical School
1 Previous Clinical Trials
69 Total Patients Enrolled
~1 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top